Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion Injury-Reference-Cited by-同舟云学术

Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion Injury

Published:2021-04-14 Issue:23 Volume:17 Page:2007727
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Guan Yu¹,Yao Weifeng¹,Yi Ke¹,Zheng Chunxiong¹²,Lv Shixian³,Tao Yu¹²,Hei Ziqing¹,Li Mingqiang¹²^ORCID

Affiliation:

1. Laboratory of Biomaterials and Translational Medicine Center for Nanomedicine Department of Anesthesiology The Third Affiliated Hospital Sun Yat‐sen University Guangzhou 510630 China

2. Guangdong Provincial Key Laboratory of Liver Disease Research Guangzhou 510630 China

3. Department of Bioengineering University of Washington Seattle WA 98195 USA

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202007727

Reference247 articles.

1. Ischemia and reperfusion—from mechanism to translation

2. Ischaemia–reperfusion injury in liver transplantation—from bench to bedside

3. Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu

4. Global Consequences of Liver Ischemia/Reperfusion Injury

5. Major Challenges Limiting Liver Transplantation in the United States

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects and Mechanisms of Fisetin against Ischemia-reperfusion Injuries: A Systematic Review;Current Pharmaceutical Biotechnology;2024-12

2. Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling;Cell Death Discovery;2024-09-10

3. Glycogen synthase kinase‐3β: A multifaceted player in ischemia‐reperfusion injury and its therapeutic prospects;Journal of Cellular Physiology;2024-07-04

4. Programmed cell death, from liver Ischemia–Reperfusion injury perspective: An overview;Heliyon;2024-07

5. Bone Marrow Mesenchymal Stem Cell Extracellular Vesicle-derived miR-27b- 3p activates the Wnt/Β-catenin Pathway by Targeting SMAD4 and Aggravates Hepatic Ischemia-reperfusion Injury;Current Stem Cell Research & Therapy;2024-07